Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-07-24Clinical Trial Update: Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating oxaliplatin in women with advanced or metastatic breast cancer that has not responded to prior chemotherapy has b…
-
CLINICAL_TRIALS withdrawal · 2012-07-13Clinical Trial Update: ELBA: Exemestane and Lapatinib in Advanced Breast Cancer [Phase 2]
A Phase 2 trial (ELBA) evaluating exemestane and lapatinib for advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-29Clinical Trial Update: Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating tipifarnib in combination with trastuzumab for metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-11Clinical Trial Update: Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer [Phase 2]
The Phase 2 trial evaluating trastuzumab in combination with exemestane for postmenopausal women with metastatic or locally advanced breast …
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer [Phase 2]
The Phase 2 BEZ235 (dactolisib) trial in HER2-negative, HR-positive metastatic breast cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-06-01Clinical Trial Update: Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial evaluating first-line chemotherapy plus hormone therapy for postmenopausal women with metastatic or locally advanced breast …
-
CLINICAL_TRIALS withdrawal · 2012-05-31Clinical Trial Update: Dendritic Cell Based Therapy for Breast Cancer Patients [Phase 2]
A Phase 2 trial of a dendritic cell–based therapy for breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-28Clinical Trial Update: Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy [Phase 1, Phase 2]
A phase 1/2 exploratory trial of topical norepinephrine in breast cancer patients undergoing radiotherapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-01Clinical Trial Update: Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease [NA]
A clinical trial investigating the use of magnetic resonance spectroscopy with MRI to determine the extent of breast cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2012-04-25Clinical Trial Update: Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy
A clinical trial investigating ductal lavage in women with early breast cancer or at high risk who are eligible for tamoxifen therapy has be…
-
CLINICAL_TRIALS withdrawal · 2012-04-18Clinical Trial Update: Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
A clinical trial evaluating a combined molecular breast imaging and breast tomosynthesis diagnostic modality has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-05Clinical Trial Update: 3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women [NA]
A clinical trial evaluating 3.0 Tesla MRI for breast cancer detection in high-risk women has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-05Clinical Trial Update: Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
The clinical trial investigating MRI of tumor response and cognitive impairment in breast cancer patients receiving chemotherapy has been wi…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: 3-Dimensional Form and Soft Tissue Biomechanics of the Breast
Clinical trial update indicating termination of the study on 3-Dimensional Form and Soft Tissue Biomechanics of the Breast; no therapeutic r…
-
CLINICAL_TRIALS withdrawal · 2012-01-04Clinical Trial Update: Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients [Phase 2]
A Phase 2 trial comparing Genexol-PM versus Paclitaxel in anthracycline-pretreated metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-12-12Clinical Trial Update: Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating cyclophosphamide and docetaxel every three weeks as neoadjuvant therapy for locally advanced breast cancer has be…
-
CLINICAL_TRIALS withdrawal · 2011-12-08Clinical Trial Update: Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer [Phase 2]
A Phase 2 trial evaluating breast-conserving surgery followed by radiation therapy for MRI-detected Stage I or Stage II breast cancer was wi…
-
CLINICAL_TRIALS withdrawal · 2011-11-02Clinical Trial Update: Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
A clinical trial (NCT00184288) evaluating proton MR spectroscopy for evaluating treatment response in brain metastases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-06-09Clinical Trial Update: Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography [Phase 3]
A Phase 3 trial comparing Nuance Full-Field Digital Mammography to screen-film mammography for diagnostic accuracy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
Clinical trial NCT00310882 has been withdrawn; it investigated the involvement of endogenous digitalis-like compounds in breast cancer.
-
CLINICAL_TRIALS withdrawal · 2011-01-28Clinical Trial Update: A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer [Phase 2]
A Phase 2 trial evaluating Iressa (gefitinib) for breast cancer has been withdrawn.
-
EMA withdrawal · 2010-12-16European Medicines Agency completes its review of Avastin used in breast cancer
EMA completes its review of Avastin's use in breast cancer, likely concluding on its safety/efficacy for this indication with regulatory act…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating goserelin acetate for preserving ovarian function in premenopausal women with breast cancer undergoing che…
-
CLINICAL_TRIALS withdrawal · 2010-11-03Clinical Trial Update: Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer [Phase 2]
A Phase 2 trial of an aminoflavone prodrug for breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-08-27Clinical Trial Update: A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer [Phase 2]
Pfizer's Phase 2 study of CP-724,714 for HER2-overexpressing metastatic breast cancer has been terminated.